FrancophonIA/ELRC3.0 huggingface dataset:
English: In addition increases in serum ALT and ALP, and reduced total protein and globulin values were recorded at the end of the treatment period in the pivotal 4-week IV dog study at the high dose (75 mg/kg) in individual dogs.
Croatian: Dodatno, u pojedinačnih pasa su, na kraju perioda liječenja u pivotalnom četverotjednom ispitivanju intravenske primjene visoke doze (75 mg/kg) na psima, zabilježeni porast ALT-a i ALP-a u serumu kao i snižene vrijednosti ukupnog proteina i globulina.
English: Clostridioides difficileassociated disease must be considered in all patients who present with diarrhoea.
Croatian: Na bolest povezanu s Clostridioides difficile mora se posumnjati u svakog bolesnika u kojeg se javi proljev.
English: Delafloxacin should be discontinued immediately at the first signs or symptoms of any serious adverse reaction and patients should be advised to contact their prescriber for advice.
Croatian: Kod prvih znakova ili simptoma bilo koje ozbiljne nuspojave primjenu delafloksacina treba odmah prekinuti, a bolesnicima savjetovati da se obrate za savjet liječniku koji im je propisao lijek.
English: • sucralfate
Croatian: • sukralfata
English: This includes tendon, muscle and joint pain of the upper and lower limbs, difficulty in walking, abnormal sensations such as pins and needles, tingling, tickling, numbness or burning
Croatian: To uključuje bol u tetivama, mišićima i zglobovima gornjih i donjih udova, otežano hodanje, abnormalne osjete kao što su bockanje, trnci, škakljanje, utrnulost ili žarenje (parestezija),
English: • Low haemoglobin level (anaemia)
Croatian: • niska razina hemoglobina (anemija)
English: Peak concentrations for the mild and moderate renal impairment patients were similar to that of healthy subjects, whereas peak concentrations were 2.1-fold, 5.9-fold and 6.4-fold higher for patients with severe renal impairment and ESRD on haemodialysis with and without haemodialysis after dosing, respectively.
Croatian: Vršne koncentracije kod bolesnika s blagim i umjerenim oštećenjem funkcije bubrega bile su slične kao kod zdravih ispitanika, dok su vršne koncentracije kod bolesnika s teškim oštećenjem bubrežne funkcije i ESRD-om na hemodijalizi, sa i bez hemodijalize nakon doziranja bile 2,1 puta, 5,9 puta odnosno 6,4 puta više.
English: After reconstitution each ml contains 25 mg of delafloxacin.
Croatian: Nakon rekonstitucije jedan ml sadrži 25 mg delafloksacina.
English: Peak plasma delafloxacin concentrations are achieved within about 1 hour after oral administration under fasting conditions.
Croatian: Vršna koncentracija delafloksacina u plazmi postiže se unutar jednog sata nakon peroralne primjene u stanju natašte.
English: Meglumine, sulfobutylbetadex sodium, disodium edetate, sodium hydroxide, hydrochloric acid, concentrated.
Croatian: Meglumin, sulfobutilbetadeksnatrij, dinatrijev edetat, natrijev hidroksid, kloridna kiselina, koncentrirana.
English: • Loss of tactile sensation at the mouth
Croatian: • gubitak osjeta dodira u ustima • smanjen osjet dodira u ustima
English: Peripheral neuropathy (including paraesthesia and hypoaesthesia) (see section 4.4) Dizziness
Croatian: glavobolja periferna neuropatija (uključujući paresteziju i hipoesteziju) (vidjeti dio 4.4) omaglica presinkopa disgeuzija
English: Hypoglycaemia (see section 4.4) Hyperglycaemia (see section 4.4) Decreased appetite
Croatian: Poremećaji metabolizma i prehrane hipoglikemija (vidjeti dio 4.4) hiperglikemija (vidjeti dio 4.4) smanjeni apetit
English: This medicine contains 2480 mg of sulfobutylbetadex sodiumin each vial.
Croatian: Ovaj lijek sadrži 2480 mg sulfobutilbetadeksnatrija u jednoj bočici.
English: A. Menarini Farmaceutica Internazionale S.R.L.
Croatian: Menarini Farmaceutica Internazionale S.R.L.
English: The safety and efficacy of the dose adjustment guidance in patients with severe renal impairment has not been clinically evaluated and is based on pharmacokinetic modelling data.
Croatian: U bolesnika s teškim oštećenjem bubrežne funkcije, sigurnost i djelotvornost smjernica za prilagodbu doze nisu klinički ocijenjene i temelje se na podacima iz farmakokinetičkog modeliranja.
English: Clostridioides difficile infection (see section 4.4) Urinary tract infection
Croatian: Infekcije i infestacije gljivična infekcija infekcija s Clostridioides difficile (vidjeti dio 4.4) infekcija urinarnog trakta sinusitis
English: • If you have ever had a problem with your tendons such as tendonitis that was related to treatment with a ‘quinolone antibiotic'.
Croatian: • ako ste ikad imali problema s Vašim tetivama poput upale tetive povezano s liječenjem
English: Patients with a family history of, or actual glucose-6-phosphate dehydrogenase deficiency are prone to haemolytic reactions when treated with other quinolones.
Croatian: Bolesnici s deficitom glukoza-6-fosfat dehidrogenaze Bolesnici s obiteljskom anamnezom nedostatka glukoza-6-fosfat dehidrogenaze ili postojećim nedostatkom skloni su hemolitičkim reakcijama za vrijeme liječenja drugim kinolonima.
English: Hepatobiliary disorders Hypertransaminasaemia Blood alkaline phosphatase increased Blood albumin decreased
Croatian: Poremećaji jetre i žuči hipertransaminazemija povišena alkalna fosfataza u krvi snižen albumin u krvi
English: The safety and efficacy of the dose recommendation in patients with severe renal impairment has not been clinically evaluated and is based on pharmacokinetic modelling data.
Croatian: U bolesnika s teškim oštećenjem bubrežne funkcije, sigurnost i djelotvornost preporučene doze nisu klinički ocijenjene i temelji se na podacima iz farmakokinetičkog modeliranja.
English: • Low blood glucose levels
Croatian: • niska razina glukoze u krvi
English: Delafloxacin is excreted both unchanged and as glucuronide metabolites in urine.
Croatian: Delafloksacin se izlučuje urinom u nepromijenjenom obliku i kao glukuronid.
English: Very rare cases of prolonged (continuing months or years), disabling and potentially irreversible serious adverse drug reactions affecting different, sometimes multiple, body systems (musculoskeletal, nervous, psychiatric and senses) have been reported in patients receiving quinolones and fluoroquinolones irrespective of their age and pre-existing risk factors.
Croatian: Zabilježeni su vrlo rijetki slučajevi dugotrajnih (koje traju mjesecima ili godinama), onesposobljavajućih i potencijalno ireverzibilnih ozbiljnih nuspojava koje zahvaćaju različite tjelesne sustave, a ponekad i više njih (mišićno-koštani, živčani, psihijatrijski i osjetilni) u bolesnika koji su primali kinolone i fluorokinolone, neovisno o njihovoj dobi i prethodno prisutnim čimbenicima rizika.
English: • Muscle and musculoskeletal pain (e.g. pain in extremity, back pain, neck pain), muscle weakness
Croatian: • bol mišića i mišićnokoštanog sustava (npr. bol u udovima, bol u leđima, bol u vratu), slabost mišića
English: Thrombocytopenia Haematocrit decreased White blood cell count decreased Haemoglobin decreased Red blood cell count decreased
Croatian: Poremećaji krvi i limfnog sustava trombocitopenija snižen hematokrit snižen broj bijelih krvnih stanica snižen hemoglobin snižen broj crvenih krvnih stanica
English: MIC breakpoints (mg/L) Susceptible (S ≤)
Croatian: Granične vrijednosti MIK (mg/l)
English: Pregnancy, women of childbearing potential not using contraception and breast-feeding (see section
Croatian: Trudnoća, žene koje mogu ostati trudne, a ne koriste kontracepciju te dojenje (vidjeti dio 4.6).
English: • The reconstituted solution must be then diluted in 250mL IV bag (either 0.9% Sodium Chloride Injection or D5W) prior to administration.
Croatian: • Rekonstituiranu otopinu zatim treba razrijediti u vrećici za intravensku primjenu od 250 ml (injekcijom 0,9% otopine natrijeva klorida ili sa D5W) prije primjene.
English: In vitro data indicate that delafloxacin at clinically relevant concentrations does not inhibit cytochrome P450 CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1 and CYP3A4/5 nor UDP glucuronosyl transferases isoforms UGT1A1 and UGT2B7.
Croatian: P450 CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1 i CYP3A4/5, niti izoforme UDP glukuronoziltransferaze UGT1A1 i UGT2B7.
English: - The other excipients are meglumine, sulfobutylbetadex sodium,disodium edetate, sodium hydroxide (for pH-adjustment), hydrochloric acid, concentrated (for pH-adjustment).
Croatian: - Druge pomoćne tvari su meglumin, sulfobutilbetadeksnatrij, dinatrijev edetat, natrijev hidroksid (za podešavanje pH), kloridna kiselina, koncentrirana (za podešavanje pH).
English: Quofenix 450 mg tablets
Croatian: Quofenix 450 mg tablete
English: • You may rarely experience symptoms of nerve damage (neuropathy) such as pain, burning, tingling, numbness and/or weakness especially in the feet and legs or hands and arms.
Croatian: • Rijetko možete osjetiti simptome oštećenja živaca (neuropatije) kao što su bol, žarenje, trnci,
English: A. Menarini - Industrie Farmaceutiche Riunite - s.r.l.
Croatian: Menarini - Industrie Farmaceutiche Riunite - s.r.l.
English: Fluoroquinolone-insusceptible microorganisms may result in superinfection with the use of delafloxacin.
Croatian: U slučaju mikroorganizama koji nisu osjetljivi na fluorokinolone, pri primjeni delafloksacina može doći do superinfekcije.
English: Each tablet contains delafloxacin meglumine equivalent to 450 mg delafloxacin.
Croatian: Jedna tableta sadrži delafloksacinmeglumin što odgovara 450 mg delafloksacina.
English: If you have any further questions on the use of this medicine, ask your doctor or nurse.
Croatian: Ako imate dodatnih pitanja u vezi s primjenom ovog lijeka, obratite se Vašem liječniku ili medicinskoj sestri.
English: Plasma protein binding of delafloxacin is not significantly affected by the degree of renal impairment.
Croatian: Stupanj oštećenja bubrežne funkcije ne utječe značajno na vezanje delafloksacina na proteine plazme.
English: No genotoxicity hazard was identified in vitro and it was negative in vivo at the highest possible dose
Croatian: Nije identificiran genotoksični rizik in vitro i bio je negativan in vivo pri najvišoj mogućoj dozi, ≥ 15 puta većoj od procijenjene izloženosti u ljudskoj plazmi temeljene na AUC.
English: • The required dose of Quofenix reconstituted solution should be aseptically transferred from the vial to a 250 mL intravenous bag.
Croatian: • Potrebnu dozu rekonstituirane otopine Quofenixa treba na aseptički način prenijeti iz bočice u vrećicu za intravensku primjenu od 250 ml. (Svu neiskorištenu rekonstituiranu otopinu mora se zbrinuti).
English: Likewise at clinically relevant concentrations delafloxacin does not inhibit the transporters MDR1, BCRP, OAT1, OAT3, OCT1, OCT2, OATP1B1, OATP1B3, MATE1, MATE2K and BSEP.
Croatian: OAT1, OAT3, OCT1, OCT2, OATP1B1, OATP1B3, MATE1, MATE2K i BSEP.
English: • Low red blood cell count (reduction of amount of blood cells)
Croatian: • niski broj crvenih krvnih stanica (smanjena količina krvnih stanica)
English: • Pain and swelling of the tendons
Croatian: • bol i oticanje tetiva
English: The use of delafloxacin is not recommended in patients with known history of myasthenia gravis.
Croatian: Primjena delafloksacina se ne preporučuje u bolesnika s miastenijom gravis u anamnezi.
English: When taking this medicine
Croatian: Kad uzimate ovaj lijek
English: • Pain and swelling in the joints and inflammation or rupture of tendons may occur rarely.
Croatian: • Rijetko se mogu pojaviti bol i oticanje zglobova te upala ili puknuće tetiva.
English: Therefore, fluoroquinolones should only be used after careful benefit-risk assessment and after consideration of other therapeutic options in patients with positive family history of aneurysm disease, or in patients diagnosed with pre-existing aortic aneurysm and/or aortic dissection, or in presence of other risk factors or conditions predisposing for aortic aneurysm and dissection (e.g. Marfan syndrome, vascular Ehlers-Danlos syndrome, Takayasu arteritis, giant cell arteritis, Behcet's disease, hypertension, known atherosclerosis).
Croatian: Stoga se fluorokinoloni smiju primjenjivati samo nakon pažljive procjene omjera koristi i rizika i nakon razmatranja drugih mogućnosti liječenja u bolesnika s aneurizmatskom bolesti u obiteljskoj anamnezi, ili u bolesnika kojima je prethodno dijagnosticirana aneurizma i/ili disekcija aorte ili u kojih postoje drugi rizični faktori ili stanja koja predstavljaju predispoziciju za aneurizmu i disekciju aorte
English: Obese patients (≥ 30 kg/m2 BMI)
Croatian: Pretili bolesnici (indeks tjelesne mase, ITM ≥ 30 kg/m2)
English: Vision blurred Dry eye
Croatian: zamagljen vid suho oko
English: Powder for concentrate for solution for infusion
Croatian: Prašak za koncentrat za otopinu za infuziju
English: Very rare cases of prolonged (up to months or years), disabling and potentially irreversible serious drug reactions affecting several, sometimes multiple, system organ classes and senses (including reactions such as tendonitis, tendon rupture, arthralgia, pain in extremities, gait disturbance, neuropathies associated with paraesthesia, depression, fatigue, memory impairment, sleep disorders, and impairment of hearing, vision, taste and smell) have been reported in association with the use of quinolones and fluoroquinolones in some cases irrespective of pre-existing risk factors (see section
Croatian: Vezano na primjenu kinolona i fluorokinolona zabilježeni su vrlo rijetki slučajevi dugotrajnih (koje traju mjesecima ili godinama), onesposobljavajućih i potencijalno ireverzibilnih ozbiljnih nuspojava koje zahvaćaju različite klase organskih sustava i osjetila, ponekad i više njih (uključujući reakcije kao što su tendinitis, ruptura tetive, artralgija, bol u udovima, poremećaj hoda, neuropatije povezane s parestezijom, depresija, umor, narušeno pamćenje, poremećaji spavanja i oštećenje sluha, vida, osjeta okusa i mirisa), u nekim slučajevima neovisno o prethodno prisutnim čimbenicima rizika (vidjeti dio
English: Each vial contains delafloxacin meglumine equivalent to 300 mg delafloxacin.
Croatian: Jedna bočica sadrži delafloksacinmeglumin što odgovara 300 mg delafloksacina.
English: • Haematocrit decreased (reduction of an indicator of amount of blood cells)
Croatian: • snižen hematokrit (sniženje pokazatelja količine krvnih stanica)
English: Oedema peripheral Local swelling Fatigue
Croatian: pireksija periferni edem lokalno oticanje umor zimica
English: Quofenix 300 mg powder for concentrate for solution for infusion
Croatian: Quofenix 300 mg prašak za koncentrat za otopinu za infuziju
English: • Reduced tactile sensation
Croatian: • smanjen osjet dodira
English: • Muscle inflammation/pain
Croatian: • upala/bol mišića
English: • Increase in the amount of enzymes produced by your liver called transaminases - shown in blood tests
Croatian: Vaša jetra zvanih transaminaze - vidljivo u krvnim pretragama • svrbež
English: If you miss a dose of Quofenix
Croatian: Ako propustite dozu Quofenixa
English: A. Menarini -Industrie Farmaceutiche Riunites.r.l.
Croatian: Menarini -Industrie Farmaceutiche Riunites.r.l.
English: Quofenix 450 mg tablets delafloxacin
Croatian: Quofenix 450 mg tablete delafloksacin
English: The mean peak exposure (Cmax) increased about 2-fold, 5-fold and 7-fold for patients with severe impairment and ESRD with and without haemodialysis after dosing, respectively compared to the normal control group.
Croatian: puta, 5 puta odnosno 7 puta kod bolesnika s teškim oštećenjem i ESRD-om sa ili bez hemodijalize nakon doziranja u odnosu na normalnu kontrolnu skupinu.
English: If women of a sexually mature age are treated, effective contraception must be used during treatment (see section 4.6).
Croatian: Ako se liječe žene u spolno zreloj dobi, tijekom liječenja se mora koristiti učinkovita kontracepcija
English: A. Menarini - Industrie Farmaceutiche Riunites.r.l.
Croatian: Menarini - Industrie Farmaceutiche Riunites.r.l.
English: Cases of sensory or sensorimotor polyneuropathy resulting in paraesthesia, hypaesthesia, dysesthesia, or weakness have been reported in patients receiving quinolones and fluoroquinolones.
Croatian: hipoesteziju, disesteziju ili slabosti u bolesnika koji su primali kinolone i fluorokinolone.
English: • Sensations like numbness, tingling, pins and needles
Croatian: • osjeti poput utrnulosti, trnaca, bockanja
English: Peak exposure (Cmax) was not statistically significantly different between renal impaired and healthy subjects.
Croatian: Razlika vršne izloženosti (Cmax) kod ispitanika s oštećenjem bubrežne funkcije i kod zdravih ispitanika nije bila statistički značajna.
English: Sodium hydroxide (for pH-adjustment) Hydrochloric acid, concentrated (for pH-adjustment)
Croatian: 6.1 Popis pomoćnih tvari meglumin sulfobutilbetadeksnatrij dinatrijev edetat natrijev hidroksid (za podešavanje pH) kloridna kiselina, koncentrirana (za podešavanje pH)
English: How to take Quofenix
Croatian: Kako uzimati Quofenix
English: • You have kidney problems.
Croatian: • ako imate probleme s bubrezima.
English: Gastrooesophageal reflux disease Paraesthesia oral Hypoaesthesia oral Glossodynia
Croatian: Poremećaji probavnog sustava proljev povraćanje mučnina erozivni gastritis stomatitis abdominalna bol dispepsija gastroezofagealni refluks oralna parestezija oralna hipoestezija glosodinija suha usta flatulencija konstipacija diskoloracija fecesa
English: This is equivalent to 2% of the recommended maximum daily dietary intake of sodium for an adult.
Croatian: preporučenog maksimalnog dnevnog unosa soli za odraslu osobu.
English: Quofenix 300 mg powder for concentrate delafloxacin
Croatian: Quofenix 300 mg prašak za koncentrat delafloksacin
English: PHARMACEUTICAL FORM
Croatian: 6. FARMACEUTSKI PODACI
English: Hypertension Hypotension Flushing Phlebitis
Croatian: Krvožilni poremećaji hipertenzija hipotenzija navale crvenila flebitis
English: Previous history of tendon disorders related to fluoroquinolone administration.
Croatian: Poremećaji tetiva povezani s primjenom fluorokinolona u anamnezi.
English: • Low white blood cell count (reduction of amount of blood cells)
Croatian: • smanjen broj bijelih krvnih stanica (smanjena količina krvnih stanica)
English: If you have any further questions on the use of this medicine, ask your doctor or pharmacist or nurse.
Croatian: U slučaju bilo kakvih pitanja u vezi s primjenom ovog lijeka, obratite se liječniku, ljekarniku ili medicinskoj sestri.
English: Blood creatine phosphokinase increased
Croatian: slabost mišića mišićni spazam povišena kreatin fosfokinaza u krvi
English: Rash Alopecia Hyperhidrosis Cold sweat Night sweat
Croatian: Poremećaji kože i potkožnog tkiva pruritus alergijski dermatitis urtikarija osip alopecija hiperhidroza hladni znoj noćno znojenje
English: Each tablet contains 450 mg of delafloxacin (as meglumine).
Croatian: Jedna tableta sadrži 450 mg delafloksacina (u obliku delafloksacinmeglumina).
English: Sodium hydrogen carbonate Sodium dihydrogen phosphate monohydrate Citric acid
Croatian: 6.1 Popis pomoćnih tvari celuloza, mikrokristalična povidon krospovidon natrijev hidrogenkarbonat natrijev dihidrogenfosfat hidrat citratna kiselina magnezijev stearat
English: Package leaflet: Information for the user Quofenix 450 mg tablets delafloxacin This medicine is subject to additional monitoring.
Croatian: Uputa o lijeku: Informacije za korisnika Quofenix 450 mg tablete delafloksacin
English: Hallucination, auditory Anxiety
Croatian: halucinacije, slušne anksioznost nesanica abnormalni snovi
English: abdominal pain, stomach discomfort/pain or indigestion, dry mouth, flatulence, discoloured faeces
Croatian: • upala sluznice želuca, upala tkiva usne šupljine, bol u trbuhu, nelagoda/bol u trbuhu ili probavne smetnje, suha usta, vjetrovi, promjena boje stolice
English: Each tablet contains 450 mg of delafloxacin (as meglumine)
Croatian: Jedna tableta sadrži 450 mg delafloksacina (u obliku delafloksacinmeglumina)
English: Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients receiving fluoroquinolone antibacterial medicinal products.
Croatian: U bolesnika liječenih fluorokinolonskim antibakterijskim lijekovima prijavljene su ozbiljne reakcije preosjetljivosti (anafilaktičke reakcije) koje su u nekim slučajevima imale smrtni ishod.
English: For dosing instructions in subjects with renal impairment refer to section 4.2.
Croatian: Za upute o doziranju kod bolesnika s oštećenjem bubrežne funkcije vidjeti dio 4.2.
English: In patients with moderate, or severe renal impairment or ESRD on haemodialysis, accumulation of the intravenous vehicle sulfobutylbetadex sodium occurs.
Croatian: Kod bolesnika s umjerenim ili teškim oštećenjem bubrežne funkcije ili s ESRD-om na hemodijalizi,
English: Dose adjustment is needed in patients with severe renal impairment (see section 4.2).
Croatian: Bolesnici s oštećenjem bubrežne funkcije Potrebno je prilagoditi dozu kod bolesnika s teškim oštećenjem bubrežne funkcije (vidjeti dio 4.2).
English: Each vial of powder contains 300 mg of delafloxacin (as meglumine).
Croatian: Jedna bočica praška sadrži 300 mg delafloksacina (u obliku delafloksacinmeglumina).
English: • Itchiness, red rash
Croatian: • svrbež, crveni osip
English: No clinically meaningful changes in delafloxacin pharmacokinetics when administered delafloxacin in patients with mild, moderate or severe hepatic impairment (Child-Pugh Class A, B and C) compared to matched healthy control subjects.
Croatian: Nisu primijećene klinički značajne razlike u farmakokinetici delafloksacina nakon primjene delafloksacina bolesnicima s blagim, umjerenim ili teškim oštećenjem funkcije jetre (Child-Pugh klase
English: How to use Quofenix
Croatian: Kako primjenjivati Quofenix
English: This medicinal product does not require any special storage conditions.
Croatian: 6.4 Posebne mjere pri čuvanju lijeka Ovaj lijek ne zahtijeva posebne uvjete čuvanja.
English: Before you are given this medicine
Croatian: Prije nego što primite ovaj lijek
English: Dyspepsia
Croatian: Disglikemija
English: Injection/infusion site reaction
Croatian: Opći poremećaji i reakcije na mjestu primjene*
English: Quofenix 300 mg powder for concentrate for solution for infusion delafloxacin
Croatian: Quofenix 300 mg prašak za koncentrat za otopinu za infuziju delafloksacin
English: • Burning sensation in the mouth
Croatian: • osjećaj pečenja u ustima • neuobičajeno znojenje
English: Package leaflet: Information for the user Quofenix 300 mg powder for concentrate for solution for infusion delafloxacin This medicine is subject to additional monitoring.
Croatian: Uputa o lijeku: Informacije za korisnika Quofenix 300 mg prašak za koncentrat za otopinu za infuziju delafloksacin
English: How to store Quofenix
Croatian: Kako čuvati Quofenix
English: Laboratorios Menarini S.A. Tel: +34-93 462 88 00
Croatian: Tel: +34-93 462 88 00
English: Each vial contains 300 mg of delafloxacin (as meglumine).
Croatian: Jedna bočica sadrži 300 mg delafloksacina (u obliku delafloksacinmeglumina).
English: Disodium edetate
Croatian: OTPADNIH MATERIJALA KOJI POTJEČU
English: When you are given this medicine
Croatian: Kad primate ovaj lijek
English: • Feeling tired
Croatian: • osjećaj umora
English: Faeces discoloured
Croatian: Neke nuspojave
English: Medical device complication
Croatian: Mehanizam djelovanja
English: тел.
Croatian: (engl.
English: Switch to delafloxacin 450 mg tablet orally every 12 hours is possible at the discretion of the physician.
Croatian: Moguć je prijelaz na peroralnu primjenu tablete delafloksacina od 450 mg svakih
English: Meglumine
Croatian: Dojenje
English: PHARMACEUTICAL PARTICULARS 6.1 List of excipients
Croatian: PRILOG I. SAŽETAK OPISA SVOJSTAVA LIJEKA
English: • Inflammation of the lining of the stomach, inflammation of the internal tissues of the mouth,
Croatian: • žgaravica / vraćanje kiseline iz želuca